Data Characteristics
Small molecule drug pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE) data, spontaneous reporting systems (e.g., FAERS, EudraVigilance), and literature. This data typically exists in both structured formats (e.g., CIOMS I forms, MedDRA codes) and unstructured forms (e.g., free-text descriptions). Update frequencies vary; spontaneous reporting system data may update daily, while clinical trial data releases are phased. Document structures include Case Report Forms (CRFs), safety database records, and medical literature abstracts. Fields cover patient demographics, drug exposure information, adverse event (AE) descriptions, severity, outcome, causality assessment, medical history, and concomitant medications. Units for dosage are commonly milligrams (mg) or grams (g), frequency is expressed as once daily or once weekly, and time in days, weeks, or months.
Constraints Imposed by These Characteristics on "HTTP Interface and External Systems"
The coexistence of highly structured and unstructured small molecule drug pharmacovigilance data requires HTTP interfaces with robust data parsing capabilities. The high update frequency of spontaneous reporting systems necessitates that interfaces support high concurrency and real-time or near real-time data retrieval and processing to avoid data lag. The presence of numerous medical terms and codes (e.g., MedDRA, ICD-10) means interfaces must ensure coding accuracy and consistency during data transfer and standardize mappings within external systems. Adverse event descriptions in unstructured text require advanced Natural Language Processing (NLP) capabilities for extraction and analysis; this may involve HTTP POST requests for large text fields. The complexity and diversity of fields demand extensible interface designs to accommodate potential future data dimensions or reporting standards.
Configuration Settings
| Configuration Item | Suggested Value | Rationale for this Value |
|---|---|---|
maxContext | 20000 characters | Handles detailed free-text descriptions in small molecule drug adverse event reports, ensuring completeness. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Processes large PDF or XML format clinical trial reports and safety database export files, which are time-consuming to parse. |
Recall count | Top 20 entries | When retrieving relevant adverse events or literature, a higher number of recall items is needed for comprehensive judgment and to reduce missed reports. |
Similarity threshold | 0.75 | Used for matching MedDRA codes or identifying similar adverse event descriptions, balancing recall and accuracy. |
Rerank result count | Top 5 entries | After initial recall, re-ranks highly relevant adverse events to focus on the most important information. |
HTTP_REQUEST_TIMEOUT | 300 seconds | Addresses slow responses from external safety databases or literature platforms, preventing data retrieval failures due to timeouts. |
Common Pitfalls
- External system JSON fields return empty, interrupting the workflow. This may be due to incorrect interface request parameters or missing data in the external system.
- When processing large volumes of historical data, HTTP requests are rate-limited by the external system due to excessive concurrency. This occurs when external API call frequencies lack limits or backoff strategies.
- Medical terms in free text are not correctly identified or standardized during adverse event name extraction. This may be due to incomplete MedDRA coding mapping rules or NLP models not optimized for the specific domain.
Verification of Configuration
- Verify that all key fields (e.g.,
patient_id,drug_name,ae_term) have correct values after data synchronization. Perform small-batch comparisons with source system data to ensure data completeness and accuracy. - Simulate high concurrency scenarios to test HTTP interface response times and success rates under sustained high pressure, ensuring compliance with external system update frequency requirements.
- Run automated test cases that include free-text parsing. Check if entities such as adverse events, drugs, and diseases are correctly extracted. Compare results against a gold standard to evaluate extraction accuracy.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.